Pharmaron Beijing Co., Ltd. (FRA:17Q1)
Germany · Delayed Price · Currency is EUR 2.360
-0.060 (-2.48%)
Last updated: Dec 1, 2025, 8:35 AM CET
Pharmaron Beijing Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 1,512 | 1,793 | 1,601 | 1,375 | 1,661 | 1,172 | Upgrade |
Depreciation & Amortization | 1,034 | 1,034 | 927.17 | 696.18 | 497.92 | 375.16 | Upgrade |
Other Amortization | 111.63 | 111.63 | 81.42 | 69.88 | 79.76 | 62.86 | Upgrade |
Loss (Gain) From Sale of Assets | 25.38 | 25.38 | -0.06 | 1.21 | 1.37 | 7.28 | Upgrade |
Asset Writedown & Restructuring Costs | 76.56 | 76.56 | -48.03 | -220.52 | -55.91 | 19.45 | Upgrade |
Loss (Gain) From Sale of Investments | -544.76 | -544.76 | -21.01 | 71.84 | -285.29 | -348.35 | Upgrade |
Provision & Write-off of Bad Debts | 42.95 | 42.95 | 35.83 | - | - | - | Upgrade |
Other Operating Activities | 1,044 | 97.19 | -25.12 | 318.9 | -38.39 | 62.79 | Upgrade |
Change in Accounts Receivable | -296.78 | -296.78 | -480.1 | -830.63 | -295.65 | -95.35 | Upgrade |
Change in Inventory | -148.07 | -148.07 | 82.43 | -120.89 | -224.88 | -120.05 | Upgrade |
Change in Accounts Payable | 327.67 | 327.67 | 461.34 | 584.09 | 641.74 | 421.54 | Upgrade |
Change in Other Net Operating Assets | 91.11 | 91.11 | 202.22 | 177.17 | 67.53 | 62.46 | Upgrade |
Operating Cash Flow | 3,242 | 2,577 | 2,754 | 2,143 | 2,058 | 1,649 | Upgrade |
Operating Cash Flow Growth | 29.97% | -6.42% | 28.50% | 4.12% | 24.83% | 75.65% | Upgrade |
Capital Expenditures | -2,442 | -2,041 | -2,865 | -2,950 | -2,093 | -1,316 | Upgrade |
Sale of Property, Plant & Equipment | 3.64 | 3.32 | 8.11 | 3.15 | 1.61 | 3.21 | Upgrade |
Cash Acquisitions | -185.75 | -22.63 | - | -1,022 | -1,226 | -791.52 | Upgrade |
Investment in Securities | -1,976 | -675.58 | 557.56 | 1,699 | -2,020 | -1,270 | Upgrade |
Other Investing Activities | 730.09 | 711.25 | 48.81 | 61.13 | 78.79 | 2.94 | Upgrade |
Investing Cash Flow | -3,870 | -2,024 | -2,251 | -2,209 | -5,258 | -3,371 | Upgrade |
Long-Term Debt Issued | - | 1,322 | 4,171 | 589.81 | 4,621 | 732.5 | Upgrade |
Long-Term Debt Repaid | - | -5,295 | -767.08 | -838.53 | -300 | -870 | Upgrade |
Net Debt Issued (Repaid) | 396.86 | -3,973 | 3,404 | -248.72 | 4,321 | -137.5 | Upgrade |
Issuance of Common Stock | 10.51 | 10.51 | 17.33 | - | - | - | Upgrade |
Repurchase of Common Stock | -285.91 | -285.91 | -0.83 | -393.38 | -284.06 | - | Upgrade |
Common Dividends Paid | -528.16 | -542.23 | -444.79 | -404.76 | -284.72 | -135.4 | Upgrade |
Other Financing Activities | 170.34 | -5.8 | 939.76 | -370.4 | -91.26 | -7.28 | Upgrade |
Financing Cash Flow | -236.36 | -4,797 | 3,915 | -1,417 | 3,661 | -280.18 | Upgrade |
Foreign Exchange Rate Adjustments | 38.42 | 78.14 | 11.43 | 72.99 | -45.52 | -85.67 | Upgrade |
Net Cash Flow | -825.62 | -4,166 | 4,429 | -1,410 | 415.78 | -2,088 | Upgrade |
Free Cash Flow | 800.2 | 536.02 | -111.78 | -807.04 | -34.78 | 332.77 | Upgrade |
Free Cash Flow Growth | 115.82% | - | - | - | - | 80.87% | Upgrade |
Free Cash Flow Margin | 5.91% | 4.37% | -0.97% | -7.86% | -0.47% | 6.48% | Upgrade |
Free Cash Flow Per Share | 0.45 | 0.30 | -0.06 | -0.45 | -0.02 | 0.19 | Upgrade |
Cash Income Tax Paid | - | 110.92 | -54.99 | -235.22 | -22 | -34.28 | Upgrade |
Levered Free Cash Flow | -745.32 | 17.01 | -1,456 | -1,678 | -479.46 | 27.17 | Upgrade |
Unlevered Free Cash Flow | -602.75 | 169.34 | -1,342 | -1,573 | -427.54 | 42.08 | Upgrade |
Change in Working Capital | -59.42 | -59.42 | 202.26 | -169.29 | 197.57 | 297.04 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.